Closed · RFA-DK-14-501 · CFDA 93.847 · Discretionary

Limited Competition for the Continuation of the Diabetes Prevention Program Outcomes Study (DPPOS) (U01)

Federal grant opportunity posted by National Institutes of Health, cataloged on Grants.gov.

up to $400K
Award range
Closed
Status
May 28, 2014
Close date
23
Expected awards

The verdict

Limited Competition for the Continuation of the Diabetes Prevention Program Outcomes Study (DPPOS) (U01) is a closed discretionary listing from National Institutes of Health that offered Up to $400,000 across 23 expected awards. Future funding cycles may be published under the same CFDA number. PlainGrants indexes 12,419 other opportunities from National Institutes of Health.

up to $400K
award range
Closed
application status
23
expected awards
93.847
CFDA program

Archived opportunity record

Limited Competition for the Continuation of t… is closed (last close May 28, 2014). The parent program page for CFDA 93.847 is the reliable place to catch re-announcements. National Institutes of Health still indexes 12,419 other opportunities here.

According to Grants.gov (extract vintage 2026-08-10), this record reflects the officially published listing. See methodology.

Deadline tracker

Application window closed

Closed May 28, 2014

Posted Mar 12 Closes May 28

Est. Total Funding

$10,000,000

Expected Awards

23

Instrument

Cooperative Agreement

Description

The purpose of this Limited Competition Funding Opportunity Announcement (FOA) is to continue follow-up of the Diabetes Prevention Program Outcomes Study (DPPOS) cohort through a cooperative agreement. The Diabetes Prevention Program (DPP) was a multi-center controlled clinical trial examining the efficacy of treatments to prevent or delay the development of type 2 diabetes in a population at high risk. The DPP demonstrated that either lifestyle change or the drug metformin could reduce the development of type 2 diabetes by 58% and 31%, respectively, compared with placebo. Following the end of DPP, the DPP cohort was enrolled in the DPPOS to determine the long-term effects of the DPP interventions on further diabetes development and microvascular complications. The primary purpose of this FOA is to continue follow-up of the DPPOS cohort to examine the effectiveness of early metformin treatment on the development of cardiovascular disease and cancer.

Catch-all / unrestricted eligibility mark · RFA-DK-14-501

Grants.gov marks Limited Competition for the Continuation of t… with a catch-all / unrestricted eligibility code (Others (see official listing text)). Read the official announcement text for the real applicant filter — the code alone is not a door list. The extract does not mark applicant cost-sharing as required. Instrument: Cooperative Agreement. Funding-activity codes span Food and Nutrition · Health (FN;HL). Only 187 other National Institutes of Health listings share this exact eligibility-code string (2% of 12,420).

Code 25
Others (see official listing text)

Codes are Grants.gov eligibility category values from the extract vintage 2026-08-10. Confirm the full eligibility statement on the official listing or the Grants.gov eligibility reference.

Official Listing on Grants.gov

View full details, application forms, and submission instructions.

View on Grants.gov

Agency Contact

NIH OER Webmaster FBOWebmaster@OD.NIH.GOV

What to do next

Limited Competition for the Continuation of t… is closed; use the parent program and agency catalog for the next funding cycle.

  • Parent CFDA 93.847 may publish future NOFOs under the same assistance listing. Open program
  • Diabetes, Endocrine, and Metabolic Disease Re… indexes 72 Grants.gov listings in this extract. Program profile
  • National Institutes of Health lists 12,419 other indexed opportunities on PlainGrants. Agency catalog

Opportunity deadlines and eligibility change on Grants.gov; PlainGrants mirrors the extract and is not the submission system.

Disclaimer: This information is sourced from Grants.gov and SAM.gov and is for informational purposes only. Opportunity details, deadlines, and eligibility requirements change frequently. Always verify current information directly on Grants.gov before applying. PlainGrants is not affiliated with any federal agency.

Data sourced from the SAM.gov Assistance Listings and Grants.gov. See our methodology for details. Retrieved and formatted by PlainGrants